Winton Group’s Kura Oncology KURA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$83.7K Sell
10,300
-23,657
-70% -$203K ﹤0.01% 1050
2025
Q4
$353K Buy
+33,957
New +$356K 0.01% 712
2022
Q2
Sell
-20,196
Closed -$325K 1015
2022
Q1
$325K Sell
20,196
-7,341
-27% -$106K 0.02% 800
2021
Q4
$386K Buy
+27,537
New +$446K 0.02% 753
2021
Q3
Sell
-12,666
Closed -$264K 1417
2021
Q2
$264K Sell
12,666
-4,639
-27% -$115K 0.01% 1253
2021
Q1
$489K Sell
17,305
-8,522
-33% -$270K 0.03% 905
2020
Q4
$844K Sell
25,827
-37,074
-59% -$1.3M 0.06% 499
2020
Q3
$1.93M Buy
62,901
+2,002
+3% +$44.2K 0.06% 540
2020
Q2
$993K Buy
60,899
+13,744
+29% +$198K 0.03% 969
2020
Q1
$469K Sell
47,155
-7,569
-14% -$86.6K 0.01% 1051
2019
Q4
$752K Buy
+54,724
New +$811K 0.01% 1132
2019
Q2
Sell
-13,579
Closed -$225K 1218
2019
Q1
$225K Sell
13,579
-272
-2% -$4.19K ﹤0.01% 915
2018
Q4
$194K Sell
13,851
-4,741
-26% -$62.8K ﹤0.01% 814
2018
Q3
$325K Buy
+18,592
New +$356K 0.01% 784

Other funds holding KURA